BioSpace News Archive

Jaguar Health, Inc. today announced that on Tuesday, January 31, 2023 Lisa Conte, Jaguar’s president, founder, and CEO, will present at the virtual Lytham Partners Investor Select Conference.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK) announces that a poster presentation highlighting the Phase 1 preliminary results of a recombinant humanized anti-claudin18.2 monoclonal antibody (AB011), as monotherapy and combination therapy, for patients with advanced solid tumors was presented at the 2023 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (“ASCO GI”), in San Francisco, California, during January 19-21, 2023.

Universal Diagnostics (Universal DX) today announced the results of an international, observational cohort study which evaluated the effectiveness of utilizing a combination of cell-free DNA (cfDNA) methylation, fragmentation and machine learning to detect early-stage colorectal cancer (CRC).

Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider and a developer of digitally simplified products, announced today it will present at the Maxim Group’s Healthcare IT Virtual Conference on Wednesday, January 25, 2023.

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s issued and outstanding common stock.

Cadrenal Therapeutics, Inc. announced today the pricing of its initial public offering of 1,400,000 shares of common stock at a public offering price of $5.00 per share, raising gross proceeds of $7,000,000 before deducting underwriting discounts and offering expenses.

Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced the appointment of three new members to the executive leadership team who will oversee and execute key aspects of commercialization and clinical research for its flagship solution, CardioFlux.

For more detail related to the fiscal year 2023 unaudited second quarter results, please visit our web site.

Jaguar Health, Inc. announced the voting results of the Company’s Special Meeting of Stockholders held on January 20, 2023 and announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock, at an exchange ratio of 1-for-75, on Monday, January 23, 2023 in order to support the Company’s compliance with Nasdaq’s listing standards.

Pixium Vision SA announces that it will hold an extraordinary general meeting of shareholders at 14:00 CET on February 15, 2023 at Pixium Vision’s headquarter office.